NCT04753268

Brief Summary

The purpose of this study is to evaluate the preliminary efficacy of a Noom Breast Cancer Weight Loss Program on weight loss outcomes, quality of life, and physical activity. Also, to qualitatively determine acceptability of this novel program among breast cancer survivors with overweight or obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 15, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

March 24, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

October 6, 2022

Status Verified

October 1, 2022

Enrollment Period

6 months

First QC Date

January 29, 2021

Last Update Submit

October 5, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Weight

    Self-reported weight

    baseline to 6 months

  • Program engagement

    Engagement with the Noom program; measured as 1. Number of App opens 2. Messages to coach 3. Number of Steps 4. Logged food 5. Logged exercise 6. Group messages and likes 7. Articles read

    weeks 1-26

  • Program retention

    i.e. % = (total participants - number of drop out) / Total number of participants) \* 100%

    weeks 1-26

  • Program satisfaction

    Satisfaction assessed via an in-house survey

    week 1 - 26 week

Study Arms (1)

Treatment group: Noom Healthy Weight Program

EXPERIMENTAL

The intervention consists of a curriculum, provided through daily articles that users are encouraged to read; logging features for weight, meals, and physical activity; in-app groups; and a virtual coach, who will communicate with participants via in-app messaging.

Behavioral: Noom Healthy Weight Program

Interventions

The intervention consists of a curriculum, provided through daily articles that users are encouraged to read; logging features for weight, meals, and physical activity; in-app groups; and a virtual coach, who will communicate with participants via in-app messaging. During the first week of the study, participants will be introduced to the program, the Noom app, and their coach. Coaches will use a secure dashboard to monitor patient progress, which is used to increase engagement and motivation. Participants are encouraged to log their weight, physical activity, and meals daily.

Treatment group: Noom Healthy Weight Program

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale survivors of breast cancer
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to understand and provide informed consent
  • years and older
  • Overweight or obesity (BMI ≥ 27.5)
  • Not 6 months postpartum
  • Not planning to become pregnant in the next 7 months
  • Have a smartphone that is compatible with Noom's mobile app
  • Breast cancer survivor with stage I, II, or III
  • Completed active treatment (e.g, surgery, chemo, radiation, etc.) \> 6 months ago

You may not qualify if:

  • Inability or unwillingness of a participant to give written informed consent
  • Currently pregnant or \< 6 months postpartum
  • Plans to become pregnant within the next 7 months
  • Stage IV, metastatic cancer or DCIS
  • Currently taking insulin
  • Uncontrolled hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Noom, Inc

New York, New York, 10001, United States

Location

Related Publications (1)

  • Shen S, Salehi E, White C, Chen Y, Iyengar NM. Evaluation of a mobile behavior change program for weight loss in breast cancer survivors. NPJ Breast Cancer. 2024 Jun 29;10(1):53. doi: 10.1038/s41523-024-00659-x.

MeSH Terms

Conditions

Weight LossHealth Behavior

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: This is a prospective, single-arm pilot study evaluating preliminary efficacy and acceptability of a Noom breast cancer survivor weight loss program. The intervention consists of a curriculum, provided through daily articles that users are encouraged to read; logging features for weight, meals, and physical activity; in-app groups; and a virtual coach, who will communicate with participants via in-app messaging. During the first week of the study, participants will be introduced to the program, the Noom app, and their coach. Coaches will use a secure dashboard to monitor patient progress, which is used to increase engagement and motivation. Participants are encouraged to log their weight, physical activity, and meals daily.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2021

First Posted

February 15, 2021

Study Start

March 24, 2021

Primary Completion

October 1, 2021

Study Completion

October 1, 2021

Last Updated

October 6, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations